|Articles|June 1, 1999

June 1999 - Special Issue
Volume 5
Issue 1 SP

New Directions in Alcohol and Drug Treatment Under Managed Care

Author(s)Constance Weisner, DRPH, MSW, Dennis McCarty, PhD, Laura Schmidt, MSW, MPH

Download PDF: New Directions in Alcohol and Drug Treatment Under Managed Care

Articles in this issue

about 27 years ago

Article

The State of Behavioral Health in Managed Care

about 27 years ago

Article

A Framework for Assessing the Effectiveness, Efficiency, and Equity of Behavioral Healthcare

about 27 years ago

Article

Implementing Effectiveness Research and Improving Care for Schizophrenia in Real-World Settings

about 27 years ago

Article

Managed Public Mental Healthcare: Issues, Trends, and Prospects

about 27 years ago

Article

Use of Performance Standards in Behavioral Health Carve-Out Contracts Among Fortune 500 Firms

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

New Directions in Alcohol and Drug Treatment Under Managed Care

Articles in this issue

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

FDA Advisory Panel Votes Against Approval of Deramiocel for DMD

Addressing Mental Health Challenges Among Black and Latino Boys

Epstein-Barr Virus Link to MS Spurs New Vaccine and T-Cell Trials

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies